Oncological long-term safety and pathological outcome evaluation for patients under active surveillance for recurrent low-risk non-muscle invasive bladder cancer: result from Bladder Cancer Italian Active Surveillance (BIAS) project

Oncological long-term safety and pathological outcome evaluation for patients under active surveillance for recurrent low-risk non-muscle invasive bladder cancer: result from Bladder Cancer Italian Active Surveillance (BIAS) project

Show other versions (1)

Bibliographic Details
Main Authors:	R. Contieri, R. Hurle, A. Saita, P. Casale, N. Buffi, G. Lughezzani, N. Frego, D. Maffei, P. Diana, F. Regis, A. Uleri, P. Avolio, V. Fasulo, M. Paciotti, M. Lazzeri, G. Guazzoni
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320356044

Similar Items

Oncological long-term safety and pathological outcome evaluation for patients under active surveillance for recurrent low-risk non-muscle invasive bladder cancer: Result from bladder cancer Italian active surveillance (BIAS) project
by: N. Frego, et al.
Published: (2020-07-01)

Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in Active Surveillance (AS) patients with recurrent Non-Muscle Invasive Bladder Cancer (NMIBC): Results from the Bladder Cancer Italian Active Surveillance (BIAS) project
by: R. Hurle, et al.
Published: (2020-07-01)

Update on the potential role of micro-ultrasound in the differentiation between muscle-invasive and non-muscle invasive bladder cancer
by: A. Uleri, et al.
Published: (2020-10-01)

Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer
by: A. Uleri, et al.
Published: (2020-10-01)

Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer
by: D. Maffei, et al.
Published: (2020-11-01)

Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience
by: Marco Paciotti, et al.
Published: (2021-04-01)

External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era
by: Nicola Frego, et al.
Published: (2022-02-01)

Head-to-head comparison between micro-ultrasound and MRI in the differentiation between muscle-invasive and non-muscle invasive bladder cancer: Results from the bladder microUS versus MRI cancer imaging staging study (BUS-MISS) protocol
by: P. Diana, et al.
Published: (2020-07-01)

Micro-ultrasound guided prostate biopsies for clinically significant prostate cancer diagnosis in a cohort of biopsy-naive patients with mpMRI
by: D. Maffei, et al.
Published: (2020-11-01)

Clincally signicant prostate cancer diagnosis by micro-ultrasound guided prostate biopsies: A real-life single center experience
by: P.P. Avolio, et al.
Published: (2020-11-01)

Clinically signicant prostate cancer diagnosis by micro-ultrasound guided prostate biopsies: A real-life single center experience
by: P.P. Avolio, et al.
Published: (2020-10-01)

Multi-institutional retrospective validation of the the Simplified PADUA REnal (SPARE) nephromatry system for the prediction of potential morbidity of nephron-sparing surgery for renal masses
by: P. Diana, et al.
Published: (2020-10-01)

The utility of micro-ultrasound in patients under active surveillance for low-risk prostate cancer: A PRIAS study extension
by: D. Maffei, et al.
Published: (2020-07-01)

Micro-ultrasound guided and MRI-targeted prostate biopsies for clinically significant prostate cancer diagnosis in the initial biopsy setting a cohort of biopsy-naive patients
by: D. Maffei, et al.
Published: (2020-10-01)

TMPRSS2: ERG expression in prostate cancer: Imaging and clinico-pathological correlations
by: V. Fasulo, et al.
Published: (2020-10-01)

Clinically significant prostate cancer diagnosis by micro-ultrasound guided prostate biopsies: A real-life single centre experience
by: D. Maffei, et al.
Published: (2020-07-01)

Micro-ultrasound guided prostate biopsies for clinically significant prostate cancer diagnosis in a cohort of biopsy-naive patients with mpMRI
by: D. Maffei, et al.
Published: (2020-07-01)

Real time High-Resolution Micro-Ultrasound guided biopsy: A new strategy to overcome systematic prostate biopsy
by: M. Paciotti, et al.
Published: (2020-10-01)

Diagnostic performance of micro-ultrasound prostate biopsies in patients undergoing mpMRI-fusion biopsies
by: D. Maffei, et al.
Published: (2020-07-01)

Assessing the relationship between micro-ultrasound results and pathology at radical prostatectomy
by: D. Maffei, et al.
Published: (2020-07-01)

Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial
by: Roberto Contieri, et al.
Published: (2022-05-01)

Laser lithotripter settings according to endoscopic view: How can we optimise the outcome? A simple way to optimise the treatment strategy
by: N. Frego, et al.
Published: (2020-07-01)

Real time high-resolution micro-ultrasound guided biopsy: A new strategy to overcome systematic prostate biopsy
by: M. Paciotti, et al.
Published: (2020-11-01)

The use of 29 MHz transrectal micro ultrasound to stratify the presence of prostate cancer in patients with an equivocal mpMRI: A single institutional analysis
by: P.P. Avolio, et al.
Published: (2020-11-01)

The use of 29 MHZ transrectal micro ultrasound to stratify the presence of prostate cancer in patients with an equivocal mpMRI: A single institutional analysis
by: P.P. Avolio, et al.
Published: (2020-10-01)

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer
by: Massimo Lazzeri, et al.
Published: (2022-09-01)

Active surveillance for nonmuscle invasive bladder cancer
by: Makito Miyake, et al.
Published: (2016-06-01)

Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence
by: Massimo Lazzeri, et al.
Published: (2016-04-01)

Biomarkers in Bladder Cancer Surveillance
by: Sukumar S. Sugeeta, et al.
Published: (2021-09-01)

A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies
by: Edoardo Beatrici, et al.
Published: (2024-03-01)

The use OF 29 MHz transrectal micro ultrasound for the local staging of prostate cancer: A single institutional analysis
by: F. Regis, et al.
Published: (2020-11-01)

Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer
by: Cesare Saitta, et al.
Published: (2023-05-01)

Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA‐repair genes
by: Vittorio Fasulo, et al.
Published: (2023-11-01)

Urinary Tumour Markers in the Diagnosis and the Surveillance of Bladder Cancer
by: Murat Binbay, et al.
Published: (2010-12-01)

Non muscle invasive bladder cancer: is active surveillance an option? our experience
by: M. Ennas, et al.
Published: (2020-10-01)

Bladder cancer: Micro RNAs as biomolecules for prognostication and surveillance
by: Nilay Mitash, et al.
Published: (2017-01-01)

Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review
by: Rui Batista, et al.
Published: (2020-01-01)

Establishment of an automated electronic registry for bladder cancer surveillance: Completing the audit cycle
by: S. O’Meara, et al.
Published: (2020-09-01)

Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment
by: Natalia Georgantzoglou, et al.
Published: (2021-03-01)

Liquid biopsy? A recent breakthrough in noninvasive bladder cancer surveillance
by: Minyong Kang, et al.
Published: (2016-09-01)